Stay updated on CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial page.

Latest updates to the CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial page
- Check4 days agoChange DetectedRevision updated to v3.4.3, replacing the previous v3.4.2 on the page. This is a routine site version update and does not alter study content or results.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2. No changes were made to the study data or other page content.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 is visible in the page header; no user-facing content changes were detected; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedUI/footer updates were applied, including adding a 'Show glossary' option and new footer items: 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'; and removing the older 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. These changes do not affect the study details or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3 in the page footer. This appears to be system versioning information and does not affect study details or user actions.SummaryDifference0.1%

- Check83 days agoChange DetectedFooter now displays Revision: v3.3.3. The HHS Vulnerability Disclosure link was removed, and Revision: v3.3.2 is no longer shown.SummaryDifference0.1%

Stay in the know with updates to CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial page.